It is remarkable that current antidiabetic drugs such as glucagon-like peptide-1 (GLP-1) agonists and metformin have been shown to downregulate Txnip expression, which may partially explain their efficacy in the treatment of diabetes mellitus [18]. The gene discussed is GLP1R; the disease is diabetes mellitus.